Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs The Coca-Cola Co K (KO) Price & Performance

Adaptive Biotechnologies CorpTrade
The Coca-Cola Co KTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs The Coca-Cola Co K — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.05B), while The Coca-Cola Co K trades at $86.31 (market cap $373.76B). The key difference: The Coca-Cola Co K is far larger — about 92.3× Adaptive Biotechnologies Corp's market cap, and The Coca-Cola Co K pays a 2.44% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.

ADPTKO
Market Cap
$4.05B$373.76B
Sector
HealthConsumer Staples
52-Week High
$25.45$89.08
52-Week Low
$12.30$65.67
Enterprise Value
$4.12B$400.93B
Volume
14,630,257
Dividend Yield
2.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Adaptive Biotechnologies Corp

No Aura AI signal available yet.

The Coca-Cola Co K

Coca-Cola (KO) trades at $86.87, down 0.21% on the day, with a bullish technical signal and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $0.97 exceeding the $0.92 forecast. Key valuation ratios include a P/E of 26.09 and ROE of 44.23%, while cash flow trends show robust operational performance. Recent news highlights institutional buying and stable demand trends ahead of Q3 earnings.

The outlook remains positive with a consensus price target of $95.83, implying 10.3% upside. Strengths include a 64-year dividend growth streak and high profitability, but risks involve regional demand divergence and elevated debt levels. Analyst sentiment is bullish with 60% buy ratings, supporting a favorable investment case for long-term holders.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About The Coca-Cola Co K

The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.

Read more on KO